Microvascular Inflammation clinical trials

Explore recruiting microvascular inflammation clinical trials.

Recruiting microvascular inflammation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Microvascular Inflammation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficiency of everolimus for the treatment of kidney transplanted patients presenting a missing self-induced NK-mediated rejection (STARR)

France

Therapeutic use (Phase IV) EU CTIS Study details

Microvascular Inflammation trials by city

Microvascular Inflammation in Toronto Microvascular Inflammation in Vancouver Microvascular Inflammation in Montreal Microvascular Inflammation in Calgary Microvascular Inflammation in Edmonton Microvascular Inflammation in Ottawa Microvascular Inflammation in Winnipeg Microvascular Inflammation in Quebec City Microvascular Inflammation in Hamilton Microvascular Inflammation in Kitchener Microvascular Inflammation in London Microvascular Inflammation in Halifax Microvascular Inflammation in New York Microvascular Inflammation in Los Angeles Microvascular Inflammation in Chicago Microvascular Inflammation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease